CAD 106

· Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAD 106, covering 2020-12-17 to 2020-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients [Phase 2]